Target audience
- Respiratory clinicians
- Cardiology clinicians
- Trainees
Educational aims
This course was designed to provide a comprehensive overview of the current state of pulmonary hypertension and pulmonary vascular disease and to understand the processes of diagnosis and management of the various pulmonary vascular conditions.
The course also discussed diagnostic techniques and new treatment modalities to help physicians managing their patients in association with their pulmonary hypertension centres.
Clinical Features of Pulmonary Hypertension S. Gaine (Dublin, Ireland)
| |
Pathobiology of pulmonary hypertension A. Peacock (Glasgow, United Kingdom)
| |
Pathophysiology of pulmonary hypertension R. Naeije (Brussels, Belgium)
| |
Exercise testing in pulmonary hypertension M. Johnson (Glasgow, United Kingdom)
| |
Imaging: echo R. Naeije (Brussels, Belgium)
| |
Imaging MR A. Vonk Noordegraaf (Amsterdam, The Netherlands)
| |
Imaging CT and V/Q M. Remy-Jardin ( Lille, France)
| |
Biomarkers M. Wilkins (London, United Kingdom)
| |
Cardiac catheterisation M. D’Alto (Naples, Italy)
| |
Making the diagnosis A. Perrier (Geneva, Switzerland)
| |
Clinical conundrums in pulmonary embolism treatment S. Gaine (Dublin, Ireland)
| |
Current medical treatment of pulmonary arterial hypertension L. Nicod (Lausanne, Switzerland)
| |
Who to treat/who not to treat: L heart disease R. Naeije (Brussels, Belgium)
| |
Who to treat/who not to treat: hypoxic lung disease A. Vonk Noordegraaf (Amsterdam, The Netherlands)
| |
Surgical treatment of pulmonary hypertension: thromboendarterectomy, atrial septostomy & transplantation J. Pepke-Zaba (Cambridge, United Kingdom)
| |
Clinical trials in PAH: what do they tell us M. Wilkins (London, United Kingdom)
| |
The future of treatment for pulmonary arterial hypertension A. Peacock (Glasgow, United Kingdom)
| |